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Abstract
Murine gammaherpesvirus 68 (HV68; MHV68) infection of mice has been a useful model for characterizing the role of conserved
herpesvirus genes in pathogenesis. One of the well conserved genes among 2-herpesvirus, gene 74, encodes a viral G-protein coupled
receptor (v-GPCR). To examine the role of the HV68 v-GPCR in pathogenesis we have generated a mutant virus in which 440 base pairs
of the gene 74 open reading frame have been deleted (HV68v-GPCR440). This deletion did not affect the growth of the virus in single
or multiple rounds of replication in vitro, nor acute replication in vivo as assessed by plaque assay of spleens and lungs on days 4, 7 and
9 post-infection (p.i.). The ability of the v-GPCR mutant virus to establish latency and to reactivate from latency was quantitated on days
16 and 42 p.i. While there was no detectable difference in the ability of the mutant virus to either establish latency or reactivate from latency
on day 16 p.i., as compared to wild-type HV68 and marker rescue virus, there was a significant decrease in the efficiency of virus
reactivation by day 42 p.i. Notably, mice infected with the mutant virus lacking the v-GPCR contained a higher frequency of viral genome
positive cells in the peritoneum by day 42 p.i. than mice infected with either wild type or marker rescue virus. However, analysis of virus
reactivation demonstrated that approximately the same frequency of cells reactivated virus from mice infected with either the HV68
v-GPCR mutant, wild-type virus, or marker rescue virus. From these experiments we conclude that the HV68 v-GPCR is dispensable for
acute virus replication in vivo, but does play a role in reactivation from latency.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The -herpesviruses include the human pathogens Ep-
stein–Barr virus (EBV) and Kaposi’s sarcoma-associated
herpesvirus (KSHV; HHV-8). These viruses establish life-
long infection of the host and are associated with a number
of malignancies. To better understand -herpesvirus patho-
genesis, we and others have begun to develop infection of
mice with murine -herpesvirus 68 (HV68; also referred to
as MHV68) as a tractable small animal model system.
HV68 is a member of the 2-herpesvirus subfamily based
on genome sequence (Efstathiou et al., 1990a; Efstathiou et
al., 1990b; Speck and Virgin, 1999; Virgin et al., 1997;
Virgin and Speck, 1999; Weck et al., 1999a).
The pathogenesis of HV68 has been reviewed recently
(Mistrikova et al., 2000; Nash and Sunil-Chandra, 1994;
Simas and Efstathiou, 1998; Speck and Virgin, 1999; Virgin
and Speck, 1999). HV68 infection of inbred mice results in
an acute, productive infection of multiple organs and a
CD4 T-cell dependent splenomegaly (Brooks et al., 1999;
Usherwood et al., 1996). Acute virus replication is cleared
by two weeks p.i. (Weck et al., 1996). Subsequently,
HV68 is present in its latent form, during which time the
HV68 genome is maintained in infected cells in the ab-
sence of detectable virus replication. HV68 establishes a
latent infection in B cells, macrophages, dendritic cells, and
persists in lung epithelial cells (Efstathiou et al., 1990b;
Flano et al., 2000; Stewart et al., 1998; Virgin and Speck,
1999; Weck et al., 1996; Weck et al., 1999a,b).
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All members of the -herpesvirus identified to date, with
the exception of EBV, contain open reading frames with
homology to G-protein coupled receptors (v-GPCRs). No-
tably, EBV induces the expression of a cellular GPCR
following infection of peripheral blood lymphocytes (Yo-
shida et al., 1997). Both KSHV and HVS encode homologs
of the IL-8 receptor, CXCR2 (Ahuja and Murphy, 1993;
Arvanitakis et al., 1997; Gershengorn et al., 1998). The viral
chemokine receptors of both KSHV and HVS have been
shown to be functional homologs, conferring the ability to
bind chemokines and activate signaling pathways in ex-
pressing cells (Ahuja and Murphy, 1993; Arvanitakis et al.,
1997; Gershengorn et al., 1998). Expression of the KSHV
v-GPCR results in constitutive activation of the ERK/p38
MAPK pathway (Munshi et al., 1999). KSHV ORF 74 also
promiscuously binds chemokines of the CXC family
(Rosenkilde et al., 1999). Transgenic mice expressing the
KSHV v-GPCR in lymphocytes developed tumors with
histologic characteristics of Kaposi’s sarcoma (Yang et al.,
2000).
The region of the HV68 genome encoding the v-GPCR
has previously been shown to be transcriptionally active in
latently infected PECs harvested from B cell-deficient
(MuMT) mice (Virgin et al., 1999). Additionally, the
HV68 v-GPCR was recently shown to induce a trans-
formed phenotype in transfected 3T3 cells at a frequency
comparable to the known viral oncogene LMP1 of EBV
(Wakeling et al., 2001). We report here the generation and
characterization of a HV68 mutant (HV68v-GPCR440)
in which the gene encoding the v-GPCR has been disrupted.
Results
Disruption of ORF 74 encoding a v-GPCR
To examine the role of ORF 74 in the replication and
pathogenesis of HV68, we constructed a mutant virus
lacking 440 base pairs internal to ORF 74 as described in
Materials and methods (HV68v-GPCR440; see Fig. 1A).
To facilitate the isolation of mutant viruses, the targeting
plasmid containing the deletion was co-transfected with
infectious HV68v-cyclin.LacZ DNA, which contains a
-galactosidase expression cassette in open reading frame
72 resulting in “blue plaques” following X-gal staining (van
Dyk et al., 2000). As the v-GPCR440 targeting plasmid
contained wild-type ORF72 sequence (and the deletion in
ORF74), viruses isolated from the co-transfection which
formed “white plaques” were further analyzed by PCR for
the presence of the deletion in ORF74. White plaques con-
taining the deletion were subjected to three additional
rounds of plaque purification. The presence of the deletion
in the genome of the mutant was confirmed by Southern blot
analyses (see Fig. 1B). Two independently derived isolates
(derived from independent transfections) of the ORF74
mutant virus were purified (HV68v-GPCR440a and
HV68v-GPCR440b) and characterized. The latter served
to control for the introduction of spurious mutations in
regions of the viral genome other than ORF74. As expected,
many of the white plaques recovered contained a rescue of
the ORF72 (v-cyclin) sequences, but did not contain the
deletion in ORF74. One of these isolates was designated
HV68v-cyclin.MR (v-cyclin.LacZ marker rescue virus)
and was used as a control in all further experiments. The
HV68v-cyclin.MR isolate has previously been extensively
characterized in the analyses of v-cyclin mutant viruses (van
Dyk et al., 2000).
As discussed above, the HV68 ORF 74 is predicted to
encode a G protein-coupled receptor which is most homol-
ogous to the host chemokine receptor CXCR2. Chemokine
receptors span the plasma membrane seven times, with their
amino-terminus located extracellularly and their carboxy-
terminus located inside the cell. The 400 bp deletion we
have introduced into ORF74 results in the deletion of se-
quences encoding residues 106 to 255 of the HV68 v-
GPCR, which are predicted to compose the first extracellu-
lar domain through the second intracellular loop. In
addition, because the deletion introduces a frame shift it
brings a translational stop codon in frame with the ORF74
coding sequence at the site of the deletion. Thus, the dele-
tion introduced results in an open reading which can only
encode the amino-terminal 105 residues of the HV68 v-
GPCR (the intact v-GPCR is 337 residues in length) and
would not be predicted to be a functional receptor.
The deletion introduced in ORF74 does not impinge on
the predicted open reading frames adjacent to ORF74 (i.e.,
ORF73 and ORF75c) (Virgin et al., 1997). However, it
should be noted that a putative polyadenylation signal for
ORF75c lies adjacent to the downstream boundary of the
deletion introduced into ORF74 (deletion spans the region
from bp 105,377 to 105,817, while the candidate ORF75c
polyadenylation signal ends at bp 105,827 in the HV68
genome) (Virgin et al., 1997). Northern blot analysis of
ORF75c transcripts expressed in murine fibroblasts infected
with either wild-type HV68 or HV68v-GPCR440 dem-
onstrated a difference in the size of the major ORF75c
transcript species (data not shown). In HV68v-GPCR440
infected cells, the major ORF75c transcript was slightly
longer than in wild type HV68 infected cells, consistent
with the utilization of a consensus polyadenylation signal
located at bp 104,317 in the viral genome. The distal poly-
adenylation signal also appeared to be used in wild-type
virus infected cells, although at a lower frequency than in
cells infected with the mutant virus. In HV68v-
GPCR440 infected cells there was also a minor transcript
species migrating at the same size as the predominant
ORF75c transcript species observed in wild-type HV68
infected cells. Importantly, the relative abundance of
ORF75c transcripts was nearly equivalent in mutant and
wild-type virus infected cells. Thus, although transcription
of ORF75c does not appear to be significantly altered, we
cannot rule out the possibility that phenotypes observed
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Fig. 1. Construction and genomic analysis of mutant viruses. A) Map of genomic regions surrounding ORF74. Co-transfection of v-cyclin.LacZ infectious
DNA with the targeting vector Clone4.1BsrGI resulted in white plaques due to the rescue of the LacZ insertion in ORF72. White plaques were then screened
for incorporation of the ORF74 deletion by PCR (see Materials and methods) and the presence of the deletion in ORF74 confirmed by Southern blot analysis
using the indicated probe. B) Southern blot analysis of v-GPCR mutant recombinants. The v-GPCR440a, v-GPCR440b, and v-GPCR440c are
independently derived recombinants generatged from three separate transfections. Three diagnostic digests are shown: PstI (P), EcoRV (RV), and BamHI (B).
The PstI digest confirms deletion of 440 base pairs from v-GPCR440 by loss of the PstI site internal to the deletion. PstI band sizes: wild type, 13.6 kB,
1.3 kB, and 1.2 kB; v-cyclin LacZ, same as wild type; v-GPCR440; 13.5 kB, 3.8 kB, and 1.3 kB. The partial digestion products seen in the wild-type PstI
digest are unique to this blot and were not routinely detected (not shown). The EcoRV and BamHI digests show rescue of the cyclin locus in v-GPCR440
mutants. EcoRV band sizes: wild type, 14.9 kB; v-cyclin LacZ, 5.0 kB,; v-GPCR440, 14.9 kB. BamHI digest: wild type, 5.2 kB; v-cyclin LacZ, 3.7 kB,
1.6 kB; v-GPCR440, 4.8 kB.
with the HV68v-GPCR440 mutant might reflect alter-
ations in ORF75c expression, as well as in the expression of
ORF74 (v-GPCR). However, it should also be noted that,
based on Northern blot analyses, ORF75c expression is
associated with lytic virus replication and, as discussed
below, the HV68v-GPCR440 mutant replicates normally
both in vitro and in vivo. The latter data make it unlikely
that the deletion in the v-GPCR has functionally altered
ORF75c expression.
HV68v-GPCR440 replicates comparably to wild-type
HV68 in vitro and in vivo
The ability to isolate a recombinant virus containing a
large deletion in the gene encoding the v-GPCR demon-
strates that ORF74 is not essential for viral replication. To
determine whether there is any role for ORF74 in viral
replication, the kinetics of wild type, HV68v-cyclin.MR,
and HV68v-GPCR440 virus replication in NIH 3T12
fibroblasts were assessed (Fig. 2). In assays to assess both
single round and multiple rounds of virus replication, the
HV68v-GPCR440 mutant was equivalent to wild type
and HV68v-cyclin.MR viruses.
We extended the in vitro replication analyses to examine
the role of ORF74 in acute virus replication in vivo. Growth
of wild-type HV68, HV68v-cyclin.MR and HV68v-
GPCR440 was assessed in the lung and spleen of C57Bl/6
mice (Fig. 3). At days 4 and 7 p.i. there were no statistically
significant differences between the replication of wild-type
HV68, HV68v-cyclin.MR, and HV68v-GPCR440 in
either the lung or spleen. By day 9 p.i. nearly all virus had
been cleared from the lungs of wild-type HV68, HV68v-
cyclin.MR, and HV68v-GPCR440 infected mice. How-
ever, at day 9 there were still significant levels of acute virus
Fig. 3. HV68v-GPCR440 replicates normally in spleen and lung of B1/6
mice during acute infection. Mice were infected with 1  106 pfu of virus
in 0.5 ml complete DMEM i.p. Organs were harvested at indicated time-
points, homogenized, and titered on NIH 3T12 monolayers as per Materials
and methods. Histograms contain data from 8 to 10 mice infected in at least
two separate experiments. The mutant virus used in these experiments was
vGPCR440a. Data regarding the ability of the mutant virus to replicate in
the liver of infected mice showed equivalent replication of all viruses at all
timepoints (not shown).
Fig. 2. Replication of HV68v-GPCR440 in fibroblasts. NIH 3T12 cells
were infected at an MOI  10 for the single step growth curve or an MOI
 0.01 for the multi-step growth curve. Following a one h incubation with
the virus at 37°C, the inoculum was removed, the monolayer washed, and
fresh media added. Individual wells were harvested at the indicated times
and samples were titered on NIH 3T12 cells monolayers. Data represents
the average of the mean of at least two independent experiments using
isolate v-GPCR440a.
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replication in the spleens of these mice. Notably, there was
a slight but statistically significant difference (P  0.036)
between the spleen titers of mice infected with HV68v-
GPCR440 and wild-type virus at day 9 p.i. Whether this
difference is biologically significant remains to be deter-
mined.
HV68 v-GPCR is dispensable for mortality in B6.Rag1-
deficient mice and after intracranial injection into 21 day
old immunocompetent mice
To extend the acute replication data, we assessed the
ability of HV68v-GPCR440 to cause mortality in
B6.Rag1-deficient following intraperitoneal infection (Fig.
4A and B). Mice were infected with either 106 or 103 pfu of
wild type, HV68v-cyclin.MR, or HV68v-GPCR440
and lethality recorded daily. B6.Rag1-deficient mice in-
fected with HV68v-GPCR440 died with similar kinetics
as those infected with wild type or parental virus. These
results are consistent with the acute replication data, and
taken together indicate that replication of the HV68v-
GPCR440 mutant virus in vivo is not significantly im-
paired. This is notable since previously published experi-
ments using rat or murine cytomegalovirus mutants lacking
a v-GPCR found a decrease in lethality (Beisser et al., 1998;
Davis-Poynter et al., 1997).
Since chemokine expression increases after viral infec-
tion of the central nervous system (see for example, refer-
ences Liu and Lane, 2001; Lokensgard et al., 2001), and
HV68 is capable of infecting numerous cell types within
the brain (Terry et al., 2000), we tested the hypothesis that
the v-GPCR might have a role in virus replication after
intracranial inoculation of 21 day old immunocompetent
CD1 mice. However, as shown in Fig. 4C, the HV68v-
GPCR440 mutant virus exhibited similar lethality to wild-
type HV68, indicating that the v-GPCR is dispensable for
virus replication in the brain. Notably, intracranial inocula-
tion of some HV68 mutants has demonstrated that this
assay can identify replication defects not detected in the
other acute virus replication assays described above. More
specifically, a mutant that disrupts the M3 gene, encoding a
high affinity chemokine binding protein (Parry et al., 2000;
van Berkel et al., 2000), and a mutant that disrupts gene 4,
encoding a regulating of complement activation (Kapadia et
al., 1999), were significantly attenuated after intracranial
inoculation but exhibited wild-type virulence after intraperi-
toneal inoculation in either immunocompetent or severely
immunocompromised mice (Kapadia et al., 2002; van Ber-
kel et al., 2002).
PECs from mice infected with HV68v-GPCR440
contain increased numbers of viral genome positive
cells at late times post infection
ORF74 has previously been shown to be preferentially
expressed in the peritoneal exudate cells (PEC) of B cell-
deficient mice latently infected with HV68 (Virgin et al.,
1999). To assess the role of the HV68 v-GPCR in the
establishment of latency, C57Bl/6J were infected, via intra-
peritoneal injection, with 1  106 pfu of either wild type,
HV68v-cyclin.MR or HV68v-GPCR440, and PECs and
splenocytes harvested on days 16 and 42 days p.i. The
frequency of cells harboring viral genome was determined
by limiting dilution PCR analysis (see Materials and meth-
ods). At early times p.i. (day 16) equivalent frequencies of
viral genome containing cells were found in the PECs and
Fig. 4. Virulence of HV68v-GPCR440 in Rag1-deficient mice and after
intracranial inoculation into 21 day old immunocompetent CD1. (A and B)
Rag 1/ mice were infected 103 (panel A) or 106 pfu (panel B) of virus
in 0.5 ml complete DMEM intraperitoneally (i.p.). Cages were checked
daily and lethality recorded. Each infectious dose was repeated at least
twice using isolate vGPCR440a. (C) Twenty-one day old CD1 mice were
infected by intracranial inoculation with the indicated doses of HV68 and
survival monitored for 14 days p.i.
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splenocytes of mice infected with either wild type,
HV68v-cyclin.MR, or HV68v-GPCR440 (Fig. 5B and
D). At late times p.i. (day 42) splenocytes from mice in-
fected with wild type, HV68v-cyclin.MR, or HV68v-
GPCR440 also contained a similar frequency of cells
harboring viral genome. However, analysis of PECs isolated
from mice infected with HV68v-GPCR440 at day 42 p.i.
contained an 8-fold higher frequency of viral genome pos-
itive cells than PECs recoverd from mice infected with wild
type or HV68v-cyclin.MR (Fig. 6B and D).
The ability of HV68 v-GPCR to reactivate from latency
was compared to that of wild type and parental virus using
a limiting dilution ex vivo reactivation assay (see Materials
and methods). Splenocytes and PECs from mice infected
with wild type, HV68v-cyclin.MR, or HV68v-
GPCR440 virus were harvested and plated onto MEF
monolayers in serial 2-fold dilutions. MEF monolayers
were subsequently monitored for the appearance of cyto-
pathic effect (CPE) for a period of 21 days. This analysis
demonstrated that splenocytes and PECs recovered from
HV68v-GPCR440 latently infected mice contain an
equivalent frequency of cells capable of reactivating virus
as wild type or HV68v-cyclin.MR virus infected mice.
This was true at both early and late times p.i. (see Figs. 5
and 6, panels A and C). At day 42 p.i. there appeared to be
a slightly higher frequency (ca. 2-fold) of HV68v-
GPCR440 infected PECs reactivating virus than either
wild type or HV68v-cyclin.MR infected PECs (see Fig.
6C). However, this slight increase in the frequency of reac-
tivating PECs at day 42 p.i. was lower than expected based
on the increase in the frequency (ca. 10-fold) of viral ge-
nome positive PECs in HV68v-GPCR440 compared to
either wild type or HV68v-cyclin.MR infected mice. Thus,
disruption of ORF74 appears to lead with time to a dimin-
Fig. 5. HV68v-GPCR440 reactivates from latency with equivalent frequency as wild type and parental virus. C57Bl/6 mice were infected with 1  106
pfu virus in 0.5 ml in complete DMEM, i.p. and PECs and splenocytes harvested 16 days p.i.. (A and C) The frequency of cells reactivating virus was
determined by limiting dilution plating PECs and splenocytes onto MEF monolayers and monitoring virus reactivation by the appearance of cytopathic effect
(cpe) (See Materials and methods). (B and D) The frequency of cells harboring virus genome was determined by limiting dilution PCR of PECs and
splenocytes (see Materials and methods). Data represents the sum of at least three independent experiments containing 5 mice per group per experiment. Data
includes results obtained from mice infected with both vGPCRD440a and vGPCRD440b (day 16 vGPCR440a, n  2; day 16 vGPCR440b, n  1; day
42 vGPCR440a, n  3; day 42 vGPCR440b, n  1).
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ished efficiency of virus reactivation from PECs. To rule out
the presence of wild-type HV68 in the viral stock of
HV68v-GPCR440, which might confound the reactiva-
tion analyses, viral DNA was isolated from wells predicted
to contain only one reactivation event. The genotype of viral
DNA isolated from these wells was then determined by
Southern blotting. All samples (n  18) contained the de-
letion in ORF74 (data not shown).
Low dose infection reveals a slight decrease in the
frequency of splenocytes reactivating virus from HV68v-
GPCR440 infected mice compared to mice infected with
either wild-type HV68 or HV68v-cyclin.MR
We have recently determined that the frequency of
splenocytes and PECs that reactivate wt HV68 upon ex
vivo cultivation is largely independent of the infecting dose
over the range from 0.1 pfu to 1  106 pfu for intraperito-
neal inoculation, and from 4 pfu to 4  105 pfu for intra-
nasal inoculation (Tibbetts et al., unpublished data). We
thus considered the possibility that high dose infection with
the HV68v-GPCR440 mutant might mask a defect in the
establishment of latency. To investigate this possibility
mice were infected via intraperitoneal inoculation with 50
pfu of either wild type, HV68v-cyclin.MR, or HV68v-
GPCR440, and PECs and splenocytes harvested on day
16 p.i. post-infection. As shown in Fig. 7, there was no
difference in the frequency of PECs reactivating virus in
mutant vs wt or marker rescue virus infected animals. How-
ever, the frequency of splenocytes reactivating virus from
HV68v-GPCR440 infected mice was ca. 3-fold lower
than splenocytes recovered from wt and marker rescue virus
infected mice (Fig. 7B).
At day 16 p.i. following low dose infection with wt
HV68 we frequently detect low levels of preformed infec-
tious virus in the spleen (e.g., see mechanically disrupted
samples in Fig. 7B). Presumably this reflects a delay in
clearing acute virus replication in the spleen after low dose
infection compared to high dose infection, where we have
not observed any preformed infectious virus by day 16 p.i.
Notably, we consistently detected lower levels of preformed
infectious virus at day 16 p.i. in HV68v-GPCR440 in-
fected mice than in either wt HV68 or HV68v-cyclin.MR
infected mice (Fig. 7B). This could reflect either a subtle
Fig. 6. PECs from C57Bl/6 mice infected with HV68 v-GPCR contain increased numbers of viral genome positive cells at late times p.i. as compared to
wild type or parental virus infected mice. C57Bl/6 mice were infected with 1  106 pfu virus in 0.5 ml in complete DMEM, i.p. and PECs and splenocytes
harvested 42 days p.i. (A and C) The frequency of cells reactivating virus was determined by limiting dilution plating PECs and splenocytes onto MEF
monolayers and monitoring virus reactivation by the appearance of cytopathic effect (cpe) (see Materials and methods). (B and D) The frequency of cells
harboring virus genome was determined by limiting dilution PCR of PECs and splenocytes (see Materials and methods). Data represent the sum of at least
three independent experiments containing 5 mice per group per experiment. Numbers of experiments performed with each viral isolate is the same as in
Fig. 5.
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defect in replication of HV68v-GPCR440 in the spleen,
and/or differences in the ability of the host immune re-
sponse to recognize and clear HV68v-GPCR440 replica-
tion.
Because route of infection might also have an impact on
the phenotype of some HV68 mutants, as we have recently
demonstrated with mutations that disrupt the M2 gene of
HV68 (Jacoby et al., 2002), we infected mice via intrana-
sal inoculation. Reactivation was assessed from splenocytes
recovered 16 days p.i. with either 1  106 pfu or 50 pfu of
virus (mutant, wt and marker rescues viruses). Notably,
there was no detectable splenic reactivation phenotype of
the v-GPCR mutant after high dose intranasal infection
(data not shown). In addition, low dose intranasal infection
did not accentuate the splenic reactivation phenotype ob-
served after low dose intraperitoneal inoculation (data not
shown). Latency in PECs was not analyzed since, in our
hands, we have observed significant variability in the estab-
lishment of latency in this reservoir post-intranasal inocu-
lation.
Discussion
Several members of the 2-herpesvirus family encode
G-protein coupled receptors. The receptors analyzed to date
are capable of both binding chemokines and signaling in
response to chemokine binding (Ahuja and Murphy, 1993;
Geras-Raaka et al., 1998a; Geras-Raaka et al., 1998b;
Geras-Raaka et al., 1998c; Gershengorn et al., 1998; Ho et
al., 1999; Murphy, 1994). Thus, to gain insights into the role
of vGPCRs in pathogenesis, we generated and characterized
infection of mice with a recombinant 2-herpesvirus virus
lacking its GPCR (HV68v-GPCR440).
HV68v-GPCR440 replicated to levels equivalent to
either wild type or HV68v-cyclin.MR virus, both in vitro
and in vivo. In addition, HV68v-GPCR440 infection of
B6.Rag1-deficient mice, or intra-cranial infection of immu-
nocompetent 21 day old CD21 mice, resulted in lethality
with similar kinetics as infection with wild type or HV68v-
cyclin.MR virus. Thus, by multiple in vivo measures of
virus replication and virulence, disruption of the HV68
v-GPCR does not adversely affect virus replication in vivo.
In contrast to the results obtained with the HV68 v-GPCR
mutant, previous studies using recombinant MCMV or
RCMV mutants lacking one of their v-GPCRs demonstrated
a defect in the ability of these mutants to induce mortality in
immunocompromised animals. This defect correlated with a
lack of spread of virus from the lungs to the salivary gland,
leading the authors to postulate a defect in trafficking of
infected cells from the primary site of infection (Beisser et
al., 1998; Beisser et al., 1999; Davis-Poynter et al., 1997).
While we did not examine trafficking of virus in RagKO
/ mice, no difference in virulence was found between
wild type and mutant virus infected animals. Moreover, as
discussed above, both wild type and mutant virus replicated
equivalently in the lungs and spleens of infected mice.
These data, in conjunction with the lethality experiments,
indicate that HV68v-GPCR440 is not impaired in either
its ability to spread from or replicate at the initial site of
infection.
While acute virus replication of HV68v-GPCR440 in
vivo appeared normal, our studies demonstrated that the
HV68 v-GPCR plays a role in virus latency, consistent
with our previous indentification of the v-GPCR as a can-
didate latency-associated gene (Virgin et al., 1999).
HV68v-GPCR440 infected mice have increased numbers
of latently infected cells in the peritoneum at late times (42
days) post-intraperitoneal infection. Equivalent numbers of
Fig. 7. Loss of HV68 v-GPCR leads to a slight decrease in the frequency
of splenocytes that reactivate virus after low dose infection. C57Bl/6 mice
were infected via intraperitoneal inoculation with 50 pfu virus in 0.5 ml
complete DMEM. At 16 days p.i., PECs and splenocytes were harvested
and the frequency of cells reactivating virus determined by limiting dilu-
tion plating PECs and splenocytes onto MEF monolayers and monitoring
virus reactivation by the appearance of cytopathic effect (cpe) (see Mate-
rials and methods). Data represents the sum of three independent experi-
ments containing 5 mice per group per experiment.
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cells from the peritoneum of mice infected with either
HV68v-GPCR440 or wild-type virus reactivate virus de-
spite the fact that more cells harbor viral genome in
HV68v-GPCR440 infected mice. Thus, HV68v-
GPCR440 infected PECs reactivate less efficiently than
PECs recovered from wild-type virus or HV68v-cy-
clin.MR infected mice at late times p.i. Upon infection with
high doses of virus (1  106 pfu), establishment and reac-
tivation from latency in the spleen was unaffected at both
early and late times p.i. However, it should be noted that
reactivation from latency is very low by day 42 p.i. and
cannot be accurately quantitated. Thus, we cannot rule out
the possibility that the HV68v-GPCR440 mutant also has
a defect in splenic reactivation at late time p.i., which is not
manifested at early times p.i. (i.e., day 16). Furthermore,
when mice were infected with a low dose of virus (50 pfu),
a small decrease in the frequency of splenocytes reactivat-
ing virus was observed in HV68v-GPCR440 infected
mice compared to wild type and marker rescue virus in-
fected animals.
With respect to the observed phenotype in PECs, there
are two obvious explanations for the observed difference in
HV68v-GPCR440 and wild type virus latency at late
times p.i. Other v-GPCRs are capable of depleting chemo-
kines from the media of infected cells. For example, cells
infected with HCMV were found to deplete RANTES from
the media (Billstrom et al., 1999) dependent on the expres-
sion of the HCMV v-GPCR, US28 (Gao and Murphy, 1994;
Kuhn et al., 1995). Notably, this function is conserved in the
-herpesviruses HHV6 and HHV7 (Isegawa et al., 1998).
Thus, the HV68 v-GPCR could be involved in removing
homeostatic chemokines from the immediate environment
of latently infected cells, thereby facilitating the movement
of infected cells out of the peritoneum. The loss of the
v-GPCR would then be expected to result in an increase in
the frequency of viral genome positive cells in the perito-
neum over time.
Alternatively, the HV68 v-GPCR may play a direct role
in facilitating migration of latently infected cells. Both the
HV68 v-GPCR and the KSHV v-GPCR, whose primary
sequences are 24% identical and 47% similar (Virgin et al.,
1997), closely resemble the host protein CXCR1. Signaling
through CXCR1 induces migration of neutrophils in re-
sponse to ligand binding (Murphy, 1997). Notably, while
the KSHV v-GPCR has been shown to be capable of pro-
miscuously binding chemokines of both the CC and CXC
families, it has also been shown that this receptor constitu-
tively signals in the absence of ligand (Arvanitakis et al.,
1997; Geras-Raaka et al., 1998a,b,c; Gershengorn et al.,
1998; Ho et al., 1999). Furthermore, binding of some
chemokines to the KSHV v-GPCR appears to alter the level
of constitutive signaling (Geras-Raaka et al., 1998b,c;
Rosenkilde et al., 1999; Rosenkilde et al., 2000). Thus, it is
possible that the HV68 v-GPCR itself induces movement
of infected cells and the absence of the HV68 v-GPCR
would then be predicted to lead to the accumulation of
latently infected cells at the site of infection (e.g., the peri-
toneum). Indeed, v-GPCR induced movement of infected
cells has already been demonstrated in the case of the
HCMV US28 v-GPCR. Infection of vascular smooth
muscle cells with an adenovirus vector containing the
US28 gene was sufficient to induce movement (Streblow
et al., 1999). Further experiments to address the ligand
binding and signaling capabilities of the HV68 v-GPCR,
as well as its ability to induce chemotaxis or chemokine-
sis, will be required to determine its precise role in this
phenotype.
While PECs contain increased numbers of cells contain-
ing viral genome following infection with HV68v-
GPCR440 compared to wild-type virus, the frequency of
cells which reactivate virus is approximately the same.
Thus, the efficiency of reactivation is decreased with the
v-GPCR mutant virus. This suggests that in addition to an
alteration in the trafficking of latently infected cells, the
v-GPCR may play a role in virus reactivation. One possi-
bility is that the HV68 v-GPCR acts as a sensor of the
extracellular environment and that signaling through the
v-GPCR modulates reactivation in some latently infected
cell type(s). Studies are underway to examine the effects of
HV68 v-GPCR expression on cellular signaling events,
and to determine whether specific CXC chemokines have an
impact on virus reactivation.
In summary, disruption of the open reading frame en-
coding the v-GPCR has no discernable impact on acute
virus replication, but does alter latency in PECs as assessed
at 6 weeks p.i. As discussed above (see Results), the 440 bp
deletion introduced within ORF74 in the HV68v-
GPCR440 mutant does not alter the adjacent open reading
frames, ORF73 and ORF75c (Virgin et al., 1997). This
deletion in ORF74 does alter which polyadenylation site the
ORF75c gene preferentially uses, but does not significantly
alter the abundance of ORF75c transcripts. Because
ORF75c is abundantly expressed during lytic virus replica-
tion, and HV68v-GPCR440 replicates normally in vitro
and in vivo, we think it is unlikely that the observed alter-
ations in ORF75c transcripts are of functional consequence.
In addition, it seems unlikely that the deletion within
ORF74 has any impact on ORF73 transcription. However,
the latter issue is very difficult to experimentally address
since ORF73, which based on homology to KSHV, ORF73
is predicted to encode a latency-associated nuclear antigen
(LANA), is a latency-associated transcript, and there are no
available in vitro latency systems to compare ORF73 ex-
pression in wild-type HV68 and HV68v-GPCR440 in-
fected cells. To rigorously address this issue we are attempt-
ing to generate an ORF73 mutant virus to assess the role of
ORF73 in virus infection. Thus, while it seems very likely
that the observed phenotype of the HV68v-GPCR440
mutant maps exclusively to the v-GPCR, we cannot rule out
an impact of this mutation on adjacent genes.
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Materials and methods
Viruses and tissue culture
HV68 WUMS strain (ATCC VR1465) was used for all
infections and is designated as wild-type (wt) HV68.
HV68 was passaged on NIH 3T12 cells for amplification
and was propagated as previously described (van Dyk et al.,
2000; Weck et al., 1996; Weck et al., 1999a,b). NIH 3T12
and MEF (mouse embryonic fibroblast) cells were main-
tained in Dulbeco’s modified Eagle’s medium (DMEM),
supplemented with 10% fetal calf serum, 100 U of penicil-
lin per ml, 100 mg of streptomycin per ml, and 2 mM
L-glutamine (complete DMEM). MEFs were obtained from
either BALB/c or C57BL/6 mouse embryos as described
previously (Weck et al., 1996).
Generation of virus mutants
All recombinant viruses were generated using Superfect
(Gibco) co-transfection of HV68 genomic DNA (36) with
the appropriate gene targeting plasmid. Recombinant vi-
ruses were purified from infected NIH 3T12 monolayers
overlaid with methylcellulose, with LacZ-expressing re-
combinants identified as blue plaques after X-gal staining of
infected monolayers (van Dyk et al., 2000).
A Not I-Spe I genomic fragment corresponding to base
pairs 95743 to 108319 in the HV68 genome was cloned
into the Not I and Spe I sites in pBluescript to create Clone
4.1. Clone 4.1 was further digested with BsrGI and re-
ligated, creating Clone 4.1BsrGI. The sequence of Clone
4.1BsrGI is identical to that of Clone 4.1 except for the
deletion of 440 base pairs between the BsrGI sites within
open reading frame of gene 74. Clone 4.1BsrGI was used
as the targeting construct to introduce the above mutation
into the genome of HV68v-cyclin.LacZ (van Dyk et al.,
2000). Co-transfection with Clone 4.1BsrGI and HV68v-
cyclin.lacZ infectious DNA resulted in white plaques due to
the rescue of the LacZ insertion in open reading frame 72.
White plaques were screened for the deletion in open read-
ing frame 74 by the polymerase chain reaction (PCR) using
the following primers: NM 11, 5-TCATTGACGCTGT
CCCTAGTGTTGC-3; NM12, 5-GCATGTAAGGGGG-
CAGATGTTTTG-3. White plaques containing the dele-
tion in open reading frame 74 were recovered and subjected
to three rounds of plaque purification as above. Following
purification multiple individual plaques were amplified on
NIH 3T12 cells in 6 well plates and their genome charac-
terized by Southern blot analysis. Two isolates (HV68v-
GPCR440a and HV68v-GPCR440b) were obtained
from separate transfections and used in all experiments to
control for the introduction of mutations at sites other then
ORF74. In parallel with the isolation of v-GPCR mutant
virus, a marker rescue virus lacking the deletion in gene 74,
but having restored the wild-type v-cyclin gene sequences
(HV68v-cyclin.MR), was purified and used to demonstrate
the absence of spurious mutants in the viral genome (see
below and van Dyk et al., 2000).
Mice, infections, and organ harvests
C57BL/6J-RagltmlMom (RAG 1/) mice were obtained
from Jackson Laboratories and were used for experiments
between 8–12 weeks of age. Lactating CD-1 outbred mice
with litters for intra-cranial infections were obtained from
Charles River Laboratories. Mice were bred and maintained
at Washington University, St. Louis, MO in accordance
with all University and Federal guidelines. C57BL/6 mice
were purchased from the Jackson Laboratories and used
between 8–12 weeks of age. Mice were placed under meto-
fane anesthesia prior to infection, as well as before sacrifice
by cervical dislocation. Unless stated otherwise, all mice
were infected with 1  106 plaque forming units (pfu) by
intraperitoneal (i.p.) injection in 0.5 ml complete DMEM.
Upon sacrifice, organs were placed in 1 ml of complete
DMEM on ice and frozen at 80°C. Resident peritoneal
exudate cells (PECs) were harvested by peritoneal lavage
with 10 ml of complete DMEM. Sentinel mice were assayed
every 3 months and were negative for adventitious mouse
pathogens by serology. For those experiments in which
virus was injected via intra-cranial inoculation, 21 day old
CD1 mice were infected with varying doses of virus in a 10
l volume using a 50 l Hamilton syringe (Hamilton Co.,
Reno, Nevada) equipped with a 30 gauge Precision-Glide
needle (Becton-Dickinson).
Plaque assay
Plaque assays were performed using NIH 3T12 mono-
layers under noble agar overlay as described previously
(Clambey et al., 2000), with the following alterations. NIH
3T12 cells were plated in 6-well plates at 2  105 cells per
well the day prior to infection. Organs to be titered were
thawed, homogenized using a tenbroeck tissue grinder, and
then ten-fold dilutions made in complete DMEM and plated
onto NIH 3T12 cell monolayers. Infections were performed
in a 100 l volume and plates were rocked every 15 minutes
for one h at 37°C. Samples were overlaid with 3 ml of a 1:1
mixture of 1% noble agar and 2 MEM supplemented with
10% FCS and 2 concentration of antibiotic and L-glu-
tamine. An additional 2 ml of noble agar, 2MEM mixture
was added between days three and six post plating. Mono-
layers were stained between day six to eight by the addition
of 2 ml of neutral red overlay (0.01% neutral red in 2
DMEM diluted 1:1 with 1% noble agar). After 18–24,
plaques were counted. The limit of detection for this assay
is 10 pfu per organ.
Limiting dilution ex vivo reactivation analyses
Detection of HV68 reactivation from latency was per-
formed as previously described (Clambey et al., 2000; van
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Dyk et al., 2000; Weck et al., 1999a). Briefly, peritoneal
exudate cells (PECs) and splenocytes were harvested be-
tween days 42 and 50 p.i., and single cell suspensions were
plated in a series of two-fold dilutions, starting at 1  105
cells per well, onto MEF monolayers in 96-well tissue
culture plates. After 21 days, wells were scored microscop-
ically for the presence of cytopathic effect (CPE). In some
cases, samples were replated on fresh MEF monolayers to
confirm the presence of infectious virus. Twenty four wells
were plated per dilution with a total of 12 dilutions per
sample per experiment. To detect preformed infectious vi-
rus, parallel samples were resuspended in 1/3 DMEM in
the presence of 0.5 mm silica beads and subjected to four
rounds of one minute mechanical disruption in a Mini-
Beadbeater-8 (Biospec Products, Bartlesville, OK) as pre-
viously described (Weck et al., 1996). This disruption pro-
cedure kills99% of cells, with at most a two-fold effect on
the titer of preformed infectious virus (Weck et al., 1996).
Disrupted cells were plated in a similar series of two-fold
dilutions.
Limiting dilution nested PCR detection of HV68
genome-positive cells
We determined the frequency of cells containing HV68
genome using a previously described nested PCR assay (LD
PCR) with ca. single copy sensitivity to detect gene 50 of
HV68 (van Dyk et al., 2000; Weck et al., 1996). Briefly,
PECs were harvested from latently infected mice and frozen
in 10% DMSO at 80°C, thawed, counted, resuspended in
an isotonic solution, and diluted in a background of 1 104
uninfected NIH 3T12 cells. After overnight lysis of cells
with proteinase K, nested PCR was performed on the sam-
ples. Twelve PCR reactions were performed for each cell
dilution with 6 dilutions per sample per experiment. With
each set of samples, 12 water controls and 12 controls for
PCR sensitivity were included. To quantitate PCR sensitiv-
ity, 10, 1 or 0.1 copies of a gene 50 containing plasmid
(pBamH I N) were diluted into a background of 1  104
uninfected cells. This PCR protocol detected 1 copy of a
gene 50 containing plasmid (pBamH I N) diluted in a
background of carrier DNA and 1  104 uninfected cells
with 50% frequency (Clambey et al., 2000; Speck, 2000;
van Dyk et al., 2000; Weck et al., 1999b).
Statistical analyses
All data were analyzed using GraphPad Prism (Graph-
Pad Software, San Diego, CA). Survival data were plotted
and statistically analyzed using the Mantel-Haenszel test.
Viral titer data were analyzed using the non-parametric,
Mann–Whitney test. The frequencies of reactivation and
genome positive cells were statistically analyzed using the
paired t test. The frequencies of cells reactivating virus, and
the frequency of cells harboring viral genome, were deter-
mined based on the Poisson distribution from the limiting
dilutions analyses as the number of cells at which 63% of
the wells scored positive.
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